The advent of artificial "spiral" blood vessels offers hope to patients with arterial obstructions

Researchers at the National Institutes of Health have developed a revolutionary artificial "spiral" blood vessel that could give life to millions of people with blocked arteriesdiseases, British media reported WednesdayTests of the new blood vessel with a rifleshowthat the blood vessel successfully completed its medical task in the human body six months before testing, which can be used in surgeryThis artificial artery is different from the blood vessels that doctors are now using because the new blood vessels have a rifle like a barrel, allowing blood to flow through the body like a bulletmotionPreviously, it had been thought that blood flowed in a straight line, and on this basis the inside of artificial blood vessels was polished very smoothlyHowever, in 1991 Professor Peter Stonebriz, from the University of Dundee, discovered that blood actually flows in a spiral, which causes less friction in blood and arteries and less damage to arteries, and helps remove blockages in blood vesselsPeter published his findings in the Lancet medical journal at the timeSince then, researchers at nhs England have been working on artificial blood vessels that mimic the human blood spiralmovementThe new vascular test spent a greatProfessor Peter set up Tayside Mobile Technologies in conjunction with others to develop the blood vessels"It may be thought that this artificial blood vessel 'grafting' will fail in natural blood vessels, but none of this pessimistic idea has materialized in the tests, " he revealedThese artificial blood vessels are doing a great job, it's amazingresearchers say that so far all of the "spiral" blood vessels have not been blocked inside, and the rate of blood flow has remained stable "We've spent millions to prove the superiority of this technology and develop this new artificial blood vessel, " says Professor Pitt We have taken a big step forward in science "
$3.
billion in the global market
Tayside Technologies is the first company set up by the British Health Service in Scotland to extend the human testing of new artificial blood vessels for another six months, but it will take up to six million pounds to start commercial production of such vessels The global market for artificial blood vessels could reach $300m (?155m) Some businesses in Scotland have decided to continue to support the technology, and they have pledged to do so, and European investors have shown a keen interest in it (reproduced from the Legal Evening News)